Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Nina-Sophie Schmidt-Hegemann"'
Autor:
Nina-Sophie Schmidt-Hegemann, Rieke von Bestenbostel, Chukwuka Eze, Mathias J. Zacherl, Minglun Li, Christian G. Stief, Christian Trapp, Paul Rogowski, Alexander Kretschmer, Harun Ilhan, Ute Ganswindt, Peter Bartenstein, Leonie Beyer, Marcus Unterrainer, Claus Belka
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:1417-1428
Purpose Nodal recurrent prostate cancer (PCa) represents a common state of disease, amenable to local therapy. PSMA-PET/CT detects PCa recurrence at low PSA levels. The aim of this study was to evaluate the outcome of PSMA-PET/CT-based salvage radiot
Autor:
Simon K. B. Spohn, Andrea Farolfi, Sarah Schandeler, Marco M. E. Vogel, Juri Ruf, Michael Mix, Simon Kirste, Francesco Ceci, Stefano Fanti, Helena Lanzafame, Francesca Serani, Christian Gratzke, August Sigle, Stephanie E. Combs, Denise Bernhardt, Juergen E. Gschwend, Josef A. Buchner, Christian Trapp, Claus Belka, Peter Bartenstein, Lena Unterrainer, Marcus Unterrainer, Matthias Eiber, Stephan G. Nekolla, Kilian Schiller, Anca L. Grosu, Nina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Jan C. Peeken
Publikováno v:
Eur. J. Nucl. Med. Mol. Imaging 50, 218-227 (2022)
Purpose This study aims to evaluate the association of the maximum standardized uptake value (SUVmax) in positron-emission tomography targeting prostate-specific membrane antigen (PSMA-PET) prior to salvage radiotherapy (sRT) on biochemical recurrenc
Autor:
Constantinos Zamboglou, Claus Belka, Nina-Sophie Schmidt-Hegemann, Wolfgang P. Fendler, Harun Ilhan, Clemens C. Cyran, Peter Bartenstein, Paul Rogowski, Christian Stief, Chukwuka Eze, Minglun Li, Alexander Buchner, Christian Schaefer, Ute Ganswindt
Publikováno v:
Journal of Nuclear Medicine. 60:963-970
(68)Ga-prostate-specific membrane antigen PET/CT ((68)Ga-PSMA PET/CT) offers unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer. Thus, we hypothesized that (68)Ga-PSMA PET/CT before radiotherapy significantly affe
Autor:
Marco M E, Vogel, Stephanie G C, Kroeze, Christoph, Henkenberens, Nina-Sophie, Schmidt-Hegemann, Simon, Kirste, Jessica, Becker, Irene A, Burger, Thorsten, Derlin, Peter, Bartenstein, Michael, Mix, Christian, la Fougère, Matthias, Eiber, Hans, Christiansen, Claus, Belka, Anca L, Grosu, Arndt-Christian, Müller, Matthias, Guckenberger, Stephanie E, Combs
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose Since the success of prostate-specific membrane antigen-positron emission tomography (PSMA-PET) imaging for patients with oligorecurrent prostate cancer (ORPC), it is increasingly used for radiotherapy as metastasis-directed therapy (MDT). Th
Autor:
Chukwuka Eze, Minglun Li, Ute Ganswindt, Harun Ilhan, Christian Schaefer, Christian G. Stief, Alexander Buchner, Alexander Kretschmer, Wolfgang P. Fendler, Peter Bartenstein, Claus Belka, Nina-Sophie Schmidt-Hegemann, Paul Rogowski
Publikováno v:
Strahlentherapie Und Onkologie
Purpose This analysis compares salvage lymph node dissection (SLND) to salvage lymph node radiotherapy (SLNRT) of 68Ga-PSMA PET-positive nodal recurrences after radical prostatectomy (RPE). Methods A total of 67 SLNRT and 33 SLND consecutive patients
Autor:
Claus Belka, Paul Rogowski, Peter Bartenstein, Nina-Sophie Schmidt-Hegemann, Alexander Buchner, Christian G. Stief, Ute Ganswindt, Chukwuka Eze, Minglun Li, Wolfgang P. Fendler, Annika Herlemann, Harun Ilhan
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Background PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients. Radiotherapy with dose escalation to t
Autor:
Nina-Sophie Schmidt-Hegemann, Thorsten D. Poeppel, Ken Herrmann, Fang-I Chu, John V. Hegde, Matthias Eiber, Francesco Ceci, Kiri A. Sandler, Michael L. Steinberg, Nicholas G. Nickols, Jeremie Calais, Amar U. Kishan, Johannes Czernin, Minsong Cao, Narek Shaverdian, Wolfgang P. Fendler, Philipp Hetkamp, Christopher R. King, Isabel Rauscher
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 59, iss 2
Target volume delineations for prostate cancer (PCa) salvage radiotherapy (SRT) after radical prostatectomy are usually drawn in the absence of visibly recurrent disease. 68Ga-labeled prostate-specific membrane antigen (PSMA-11) PET/CT detects recurr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942dee3c876ddbad9893a4b484899f18
http://hdl.handle.net/11585/626387
http://hdl.handle.net/11585/626387
Autor:
Maximilian Niyazi, Alexander Buchner, Christian G. Stief, Ute Ganswindt, Paul Rogowski, Chukwuka Eze, Minglun Li, Claus Belka, Peter Bartenstein, Wolfgang P. Fendler, Nina-Sophie Schmidt-Hegemann
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 12, Iss 1, Pp 1-9 (2017)
Radiation Oncology, Vol 12, Iss 1, Pp 1-9 (2017)
Background To determine the potential role of 68Ga-PSMA positron emission tomography/computed tomography (PET/CT) in radiotherapy (RT) planning for prostate cancer (PCa). Methods One hundred twenty-nine patients (pts) with 68Ga-PSMA PET/CT were retro